Cianna Medical Reports Extraordinary Growth for SCOUT® Radar Localization System
May 31, 2017 11:03 am UTC| Business
ALISO VIEJO, Calif., May 31, 2017 -- Cianna Medical, Inc., today announced that it is doubling its sales force and adding to its clinical application support team to meet the growing demand for its proprietary SCOUT®...
Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
May 31, 2017 11:03 am UTC| Business
On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in Mid-2017 NETSPOT® Unit Sales per Month Jump 140% During First Quarter First Quarter 2017 Highlights: Advanced preparations for resubmission...
Cianna Medical Reports Extraordinary Growth for SCOUT® Radar Localization System
May 31, 2017 11:03 am UTC| Business
ALISO VIEJO, Calif., May 31, 2017 -- Cianna Medical, Inc., today announced that it is doubling its sales force and adding to its clinical application support team to meet the growing demand for its proprietary SCOUT®...
Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
May 31, 2017 11:02 am UTC| Business
On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in Mid-2017 NETSPOT® Unit Sales per Month Jump 140% During First Quarter First Quarter 2017 Highlights: Advanced preparations for resubmission...
Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
May 31, 2017 11:02 am UTC| Business
On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in Mid-2017 NETSPOT® Unit Sales per Month Jump 140% During First Quarter First Quarter 2017 Highlights: Advanced preparations for resubmission...
Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
May 31, 2017 11:02 am UTC| Business
On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in Mid-2017 NETSPOT® Unit Sales per Month Jump 140% During First Quarter First Quarter 2017 Highlights: Advanced preparations for resubmission...
Karyopharm Therapeutics to Participate in Upcoming Investor Conferences
May 31, 2017 11:01 am UTC| Business
NEWTON, Mass., May 31, 2017 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive Officer, will participate in the...